Category: Alternative & Complementary Medicine
Europe Alternative & Complementary Medicine
-
Cannabis Extract Market, by Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol), by Product Type (Oil, Shatter, Wax, Hash, Others (Gummies, Cream, etc.)), by Extract Type (Full Spectrum, Broad Spectrum, Isolates), by Indication (Muscle Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Disorder (Dystonia), Neurological Disorder (Parkinson Disease), Pain Management, Recreational Use), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, ... Read More
-
Cannabis Testing Services Market, by Test Type (Potency Testing, Terpene Profiling, Cannabinoid Profiling [CBD Testing and THC Testing], Pesticide Screening, Residual Solvent Testing, Microbiological Screening, and Other Tests), by Product Type (Instruments [Chromatography Instruments {Liquid Chromatography, Gas Chromatography, and Others}, Spectroscopy Instruments {Mass Spectroscopy and Atomic Spectroscopy}, Other Instruments], and Consumables & Test Kits), by End Users (Testing Laboratories, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Chromatography, Gas Chromatography, and Others}, Spectroscopy Instruments {Mass Spectroscopy and Atomic Spectroscopy}, Other Instruments], and Consumables & Test Kits), by End Users (Testing Laboratories, Research Institutes, and Others), and by Region (North America, Latin America, ... Read More
-
Europe Minor Cannabinoids Market Databank
... Cannabigerol (CBG) segment is expected to be the highest contributor to this market, with $2,174.2 Million in 2020, and is anticipated to reach $4,198.5 Million by 2029, registering a CAGR of 7.64%. Cannabigerolic acid (CBGA) ... Read More
-
Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report By Brand Type (Sativex, Epidiolex), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2022 - 2028
... to expand at a CAGR of 104.2% from 2022 to 2028. Rapid growth in applications of cannabis for various indications including pain, inflammation, sleep disorders, anorexia, epilepsy, schizophrenia, and multiple sclerosis is estimated to drive ... Read More
Research Assistance
